300529 健帆生物
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额573,2401,050,988916,744883,8001,249,415
投资活动产生之现金流量净额(1,242,420)(1,127,472)(249,649)(305,901)(670,220)
筹资活动产生之现金流量净额(596,470)(989,821)(451,911)(365,934)165,175
汇率变动对现金及现金等价物的影响(525)42811(36)0
现金及现金等价物净增加/(减少)(1,266,175)(1,065,877)215,195211,929744,370
期初现金及现金等价物余额1,675,6662,741,5432,526,3492,314,4201,570,050
期末现金及现金等价物余额409,4911,675,6662,741,5432,526,3492,314,420